Cargando…
Optimized 4,5-Diarylimidazoles as Potent/Selective Inhibitors of Protein Kinase CK1δ and Their Structural Relation to p38α MAPK
The involvement of protein kinase CK1δ in the pathogenesis of severe disorders such as Alzheimer’s disease, amyotrophic lateral sclerosis, familial advanced sleep phase syndrome, and cancer has dramatically increased interest in the development of effective small molecule inhibitors for both therape...
Autores principales: | Halekotte, Jakob, Witt, Lydia, Ianes, Chiara, Krüger, Marc, Bührmann, Mike, Rauh, Daniel, Pichlo, Christian, Brunstein, Elena, Luxenburger, Andreas, Baumann, Ulrich, Knippschild, Uwe, Bischof, Joachim, Peifer, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6154583/ https://www.ncbi.nlm.nih.gov/pubmed/28338621 http://dx.doi.org/10.3390/molecules22040522 |
Ejemplares similares
-
Design, Synthesis and Biological Evaluation of Isoxazole-Based CK1 Inhibitors Modified with Chiral Pyrrolidine Scaffolds
por: Luxenburger, Andreas, et al.
Publicado: (2019) -
A CK1 FRET biosensor reveals that DDX3X is an essential activator of CK1ε
por: Dolde, Christine, et al.
Publicado: (2018) -
The CK1 Family: Contribution to Cellular Stress Response and Its Role in Carcinogenesis
por: Knippschild, Uwe, et al.
Publicado: (2014) -
Newly Developed CK1-Specific Inhibitors Show Specifically Stronger Effects on CK1 Mutants and Colon Cancer Cell Lines
por: Liu, Congxing, et al.
Publicado: (2019) -
CK1δ in lymphoma: gene expression and mutation analyses and validation of CK1δ kinase activity for therapeutic application
por: Winkler, B. Sophia, et al.
Publicado: (2015)